Brilliant mate, really appreciate you sharing your thoughts.
Two questions if I may,
1) Would they only get access to the database results post it being locked and how long do you imagine it would take for a top line readout?
2) You said you were impressed with the phase 2 results, are you worried about the population size and lack of response in 75mm?
Lopez I haven’t heard anything further on Merck’s use of Viralytics, other than most of that team are now on another Aussie company. If I do hear I will let you know.
Ann: DMC Completes Final Review of Phase 3 Heart Failure Trial, page-51
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.080(8.42%) |
Mkt cap ! $1.176B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | $1.03 | 95.0¢ | $43.38M | 42.28M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 72752 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 205100 | 2 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |